Search Results 851-860 of 21746 for Analysis
... analysis. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
Implications of CA19-9 elevation for survival, staging and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis. Journal of ...
Key Insight: This presentation includes the final analysis of the MOUNTAINEER trial and reaffirms the clinically meaningful anti-tumor activity and ...
... Analysis. Int J Gynecol Pathol. 2025 Jul 1; 44 (4):355-357 Epub 2024 July 23 ... Analysis of MDM2 Amplification in 43 Endometrial Stromal Tumors: A Potential ...
Mayo Clinic researcher David M. Zahrieh, Ph.D., focuses on the design, conduct, reporting and analysis of randomized clinical trials that incorporate ...
... analysis of these now routinely collected clinical outcomes. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
The purpose of this study is an effort to enrich the ongoing NOHARM pragmatic trial. NOHARM AIM 3 will use a mixed methods analysis of patient and care team ...
... analysis. If the pembrolizumab Low Dose arm is closed, participants may receive pembrolizumab High Dose therapy. Participation eligibility. Participant ...
This effect was associated with a halving of the rate of composite ASCVD end points in a post hoc analysis. Placebo- as well as ezetimibe-controlled trials ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.